Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Vitiligo in Germany : A claims data analysis on prevalence, comorbidity, and treatment patterns
Journal: Dermatologie (Heidelberg, Germany)
Published: April 23, 2026
Prolonged ruxolitinib cream treatment for vitiligo among patients with no or limited response in the first 6 months.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: November 07, 2025
Hyaluronic Acid Filler CPM-V ± Lidocaine for Chin Augmentation: A Randomized, Multicenter, Open-Label Post-Market Follow-Up Study.
Journal: Clinical, cosmetic and investigational dermatology
Published: November 05, 2025
S3 Guideline for the treatment of psoriasis vulgaris, adapted from EuroGuiDerm - part 1: Treatment recommendations and monitoring.
Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: September 23, 2025
S3 Guideline for the Treatment of Psoriasis vulgaris, adapted from EuroGuiDerm - part 2: Specific clinical and comorbid situations.
Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: September 23, 2025
Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trials.
Journal: Lancet (London, England)
Published: July 08, 2025
Open-label treatment extension of ruxolitinib cream in vitiligo: findings from the TRuE-V long-term extension phase 3 study.
Journal: The British journal of dermatology
Published: June 25, 2025
Open-label treatment extension of ruxolitinib cream in vitiligo: findings from the Topical Ruxolitinib Evaluation in Vitiligo (TRuE-V) long-term extension phase III study.
Journal: The British journal of dermatology
Published: June 25, 2025
Randomized, double-blind treatment withdrawal or continuation with ruxolitinib cream in vitiligo: findings from the TRuE-V long-term extension phase 3 study.
Journal: The British journal of dermatology
Published: June 13, 2025
Single-Injection Options for Administering a 320 mg Dose of Bimekizumab: 2 mL Safety Syringe and Auto-injector.
Journal: Dermatology and therapy
Published: December 22, 2024
Exploring Burnout among Nursing Students in Bangalore: A t-Distributed Stochastic Neighbor Embedding Analysis and Hierarchical Clustering in Cross-Sectional Data.
Journal: Nursing reports (Pavia, Italy)
Published: April 28, 2024
Indication for systemic therapy in chronic prurigo: Annotated checklist for practice.
Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: September 19, 2023
Last Updated: 09/26/2026